BlackRock Advisors’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History
Bought
Maintained
Sold
Other funds holding SPPI
BFA
BIT
BlackRock Advisors's SPPI Position: Q4 2016 in Review
BlackRock Advisors reduced its Spectrum Pharmaceuticals Inc (SPPI) stake by 1.8% in Q4 2016, selling an estimated $14.4K and leaving 185,952 shares worth $824K. The position accounts for ﹤0.01% of the portfolio, ranked #1956.
BlackRock Advisors first reported a position in SPPI in Q2 2013 and has held it in 15 quarters since. The position peaked at $2.26M in Q4 2014. 139 funds tracked by Wall St. Rank hold SPPI as of Q4 2016.
- BlackRock Advisors held 185,952 shares of Spectrum Pharmaceuticals Inc worth $824K as of Q4 2016.
- BlackRock Advisors sold 3,422 Spectrum Pharmaceuticals Inc shares in Q4 2016, an estimated $14.4K.
- Spectrum Pharmaceuticals Inc made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #1956 holding.
- BlackRock Advisors first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and has held it in 15 quarters since.
- BlackRock Advisors's Spectrum Pharmaceuticals Inc position peaked at $2.26M in Q4 2014.
- 139 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2016.
Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.